Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies. METHODS: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B12 and B6. RESULTS: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled. CONCLUSIONS: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adjudication for Alzheimer’s phenotypes was done by a committee41, comprising at least two neurologists and a neuropsychologist.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [41]
In the citing paper
“Dementia diagnoses were made according to DSM‐IV criteria, based on longitudinal cognitive assessments, caregiver interviews, medical records, neuroimaging, and autopsy data when available.”
From Blood PCSK9 Impacts Alzheimer's Disease Risk in an APOE Genotype‐Dependent Manner: A Prospective Cohort Study (2026) · cites this paper as [18]
In the citing paper
“Overall, of the 19 selected cohort studies linking Hcy to the various cognitive outcomes, 12(63.2%) found the relationship in the hypothesized direction in the entire population that was studied and for most outcomes of interest [206,215,217,219,222-224,228,231,233-235]”
From Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis (2014) · cites this paper as [206]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Homocysteine and Atherothrombosis
Welch, G. N., & Loscalzo, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804093381507 · Cited by 1,997
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationBrookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Research works printed but not linked: 3
- Berg L, 1988, Psychopharmacol Bull, 24, 637
- Levin ML, 1953, Acta Unio Int Contr Cancrum, 9, 531
- 1996, Fed Regist, 61, 8781
Cited by
Items 101–200 of 1,022
Fruit and vegetable consumption and cognitive decline in aging women
Kang, J. H., Ascherio, A., & Grodstein, F. (2005) · Annals of Neurology · doi:10.1002/ana.20476 · Cited by 303
“Folate also has been linked to cognitive function and dementia in epidemiological studies.(14,16,17,49,50) Folate deficiency can lead to high homocysteine levels, which has direct neurotoxic effects in cell lines and animal models.”
BackgroundMolecular Mechanisms and Potential Clinical Significance of S -Glutathionylation
Dalle–Donne, I., Milzani, A., Gagliano, N., Colombo, R., Giustarini, D., & Rossi, R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1716 · Cited by 297
“Interest-ingly, elevated plasma homocysteine is a strong, independent risk factor for the development of AD (234) and elevated brain homocysteine has been reported in AD (71).”
Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin
Rosales‐Corral, S. A., Acuña‐Castroviejo, D., Coto‐Montes, A., Boga, J. A., Manchester, L. C., Fuentes‐Broto, L., Korkmaz, A., Ma, S., Tan, D. X., & Reiter, R. J. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00937.x · Cited by 294
“Even more so, high homocysteine levels, considered a risk factor for dementia and AD [29], are related to apoptosis [181].”
BackgroundA Highly Selective Fluorescent Probe for Thiophenols
Jiang, W., Fu, Q., Fan, H., Ho, J., & Wang, W. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200702271 · Cited by 292
Mastroeni, D., McKee, A., Grover, A., Rogers, J., & Coleman, P. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006617 · Cited by 294
“More specifically, they may provide a rationale for the consistent epidemiologic and neuropathologic association of AD with homocysteine elevation and folate deficiencies [15,16], since folate ultimately provides the methyl group for DNA methylation.”
BackgroundSamsel, A., & Seneff, S. (2013) · Entropy · doi:10.3390/e15041416 · Cited by 293
“Elevated serum homocysteine is a strong risk factor in cardiovascular disease [191], in heart failure [192], in dementia [193], and in kidney failure [194,195].”
BackgroundNeuroprotective Actions of Dietary Choline
Blusztajn, J., Slack, B., & Mellott, T. (2017) · Nutrients · doi:10.3390/nu9080815 · Cited by 293
“In 2002, a prospective evaluation of dementia-free FHS Generation 1 subjects showed that elevations in plasma homocysteine concentrations over eight years prior to the onset of clinical dementia predicted the subsequent development of AD [215].”
BackgroundA thiol-specific fluorescent probe and its application for bioimaging
Chen, X., Ko, S.-K., Kim, M. J., Shin, I., & Yoon, J. (2010) · Chemical Communications · doi:10.1039/b925453f · Cited by 289
Mattson, M. P., Duan, W., & Guo, Z. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01586.x · Cited by 288
“It will be of considerable interest to determine whether DR can also protect neurons against the adverse effects of folic acid deficiency, which has recently been linked to the pathogenesis of AD, PD and stroke (Duan et al. 2002; Kruman et al. 2002; Seshadri et al. 2002).”
BackgroundStein, T. D., & Johnson, J. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07380.2002 · Cited by 288
Atherosclerosis and AD: Analysis of data from the US National Alzheimer’s Coordinating Center
Honig, L. S., Kukull, W., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000150886.50187.30 · Cited by 284
Therapy insight, type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease
Haan, M. N. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0124 · Cited by 284
Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics
Duce, J. A., & Bush, A. I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.003 · Cited by 283
De Bree, A., Verschuren, W. M. M., Kromhout, D., Kluijtmans, L. A. J., & Blom, H. J. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.599 · Cited by 282
Homocysteine and brain atrophy on MRI of non-demented elderly
den Heijer, T., Vermeer, S. E., Clarke, R., Oudkerk, M., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2003) · Brain · doi:10.1093/brain/awg006 · Cited by 282
“Furthermore, they are in keeping with a prospective study which showed that a high plasma homocysteine level is an independent risk factor for Alzheimer's disease (Seshadri et al., 2002).”
BackgroundResultInfluentialCircle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease
Roher, A. E., Esh, C., Kokjohn, T. A., Kalback, W., Luehrs, D. C., Seward, J. D., Sue, L. I., & Beach, T. G. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000095973.42032.44 · Cited by 280
Causes of hyperhomocysteinemia and its pathological significance
Kim, J., Kim, H., Roh, H., & Kwon, Y. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1016-4 · Cited by 276
“A prospective study in 2002 revealed that elevated homocysteine level was an independent risk factor for Alzheimer’s disease because the incidence rate of dementia in hyperhomocysteinemia patients was not affected by the provision of vitamins (Seshadri et al. 2002).”
BackgroundIANA task force on nutrition and cognitive decline with aging.
Guyonnet, S., van Kan, G. A., Andrieu, S., Barberger‐Gateau, P., Berr, C., Bonnefoy, M., Dartigues, J. F., de Groot, C. P. G. M., Ferry, M., Galan, P., et al. (2007) · PubMed · Cited by 315
Malouf, R., & Grimley Evans, J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004514.pub2 · Cited by 277
Fiest, K. M., Roberts, J. I., Maxwell, C. J., Hogan, D. B., Smith, E. E., Frolkis, A., Cohen, A., Kirk, A., Pearson, D., Pringsheim, T., et al. (2016) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2016.36 · Cited by 272
“Fourteen studies reported on the incidence proportion of AD,(104-117) with six included in the meta-analysis of 60 + studies.(107,108,111,113,114,116) In community settings, the pooled annual incidence proportion among those aged 60+ was 34.”
BackgroundA fluorescein-based probe with high selectivity to cysteine over homocysteine and glutathione
Wang, H., Zhou, G., Gai, H., & Chen, X. (2012) · Chemical Communications · doi:10.1039/c2cc33932c · Cited by 271
Biomarkers of Alzheimer disease in plasma
Irizarry, M. C. (2004) · NeuroRX · doi:10.1602/neurorx.1.2.226 · Cited by 268
“Elevated homocysteine is a risk factor for cardiovascular disease,(79) and seems to be an independent risk factor for AD.(80) Hyperhomocystenemia is associated with relative deficiencies of folate, B6, and B12, and with age, male sex, estrogen deficit, renal insufficiency, caffeine use, dopamine agonist use, and antic…”
BackgroundPapp, K. V., Walsh, S. J., & Snyder, P. J. (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2008.10.008 · Cited by 269
“57, respectively [40,41].”
Selective Phosphorescence Chemosensor for Homocysteine Based on an Iridium(III) Complex
Chen, H., Zhao, Q., Wu, Y., Li, F., Yang, H., Yi, T., & Huang, C. (2007) · Inorganic Chemistry · doi:10.1021/ic7010887 · Cited by 269
Kado, D. M., Karlamangla, A. S., Huang, M.-H., Troen, A., Rowe, J. W., Selhub, J., & Seeman, T. E. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.08.019 · Cited by 268
Self-citationThe role of metallobiology and amyloid-β peptides in Alzheimer's disease
Roberts, B. R., Ryan, T. M., Bush, A. I., Masters, C. L., & Duce, J. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07500.x · Cited by 266
“Elevated levels of homocysteine can double the risk of developing AD (Seshadri et al. 2002) whereas folate deficiency may contribute to the progression of AD (Prodan et al.”
BackgroundDietary Folate and Vitamin B12 Intake and Cognitive Decline Among Community-Dwelling Older Persons
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Hebert, L. E., Scherr, P. A., & Schneider, J. A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.4.641 · Cited by 264
The Homocysteine Hypothesis of Depression
Folstein, M., Liu, T., Peter, I., Buel, J., Arsenault, L., Scott, T., & Qiu, W. W. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.861 · Cited by 262
“Some studies find elevated levels of homocysteine in Alzheimer’s disease (7, 8) and cognitive impairment (9), but others do not (10, 11).”
BackgroundPhytochemical and Dietary Fiber Components in Barley Varieties in the HEALTHGRAIN Diversity Screen
Andersson, A. A. M., Lampi, A.-M., Nyström, L., Piironen, V., Li, L., Ward, J. L., Gebruers, K., Courtin, C. M., Delcour, J. A., Boros, D., et al. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf802037f · Cited by 262
Homocysteine – from disease biomarker to disease prevention
Smith, A. D., & Refsum, H. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13279 · Cited by 261
McMahon, B. K., & Gunnlaugsson, T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja300887k · Cited by 261
Haan, M. N., Miller, J. W., Aiello, A. E., Whitmer, R. A., Jagust, W. J., Mungas, D. M., Allen, L. H., & Green, R. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.511 · Cited by 260
“However, findings from the Framingham Study (1, 34) and the current study, both of which have D ow nloaded from https://academ ic.oup.com /ajcn/article-abstract/85/2/511/4649538 by guest on 15 M arch 2020 longer follow-up times, suggest that homocysteine may be an independent predictor of dementia outcomes.”
BackgroundInfluentialCyclic changes in metabolic state during the life of a yeast cell
Tu, B. P., Mohler, R. E., Liu, J. C., Dombek, K. M., Young, E. T., Synovec, R. E., & McKnight, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708365104 · Cited by 258
Molecular basis of homocysteine toxicity in humans
Jakubowski, H. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3204-7 · Cited by 255
Epigenetic mechanisms in Alzheimer's disease
Mastroeni, D., Grover, A., Delvaux, E., Whiteside, C., Coleman, P. D., & Rogers, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.017 · Cited by 253
“Elevated plasma hoocysteine has been reported to be a significant risk factor or AD in dementia-free cohorts of both the Framingham tudy of Aging (Seshadri et al., 2002) and the Conselice tudy of Brain Aging (Ravaglia et al.”
BackgroundHomocysteine and cognitive function in the elderly: The Rotterdam Scan Study
Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., Jolles, J., Clarke, R., & Breteler, M. M. B. (2002) · Neurology · doi:10.1212/01.wnl.0000032494.05619.93 · Cited by 254
“Carotid plaque score, median (interquartile range) 1 (0; 3 )”
Biological markers for therapeutic trials in Alzheimer’s disease
Frank, R. A., Galasko, D., Hampel, H., Hardy, J., de Leon, M. J., Mehta, P. D., Rogers, J., Siemers, E., & Trojanowski, J. Q. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00002-2 · Cited by 252
“In the Framingham study, plasma homocysteine levels greater than 14 umol/l almost doubled the risk of AD [130].”
BackgroundNutrients and bioactives in green leafy vegetables and cognitive decline: Prospective study
Morris, M. C., Wang, Y., Barnes, L. L., Bennett, D. A., Dawson-Hughes, B., & Booth, S. L. (2018) · Neurology · doi:10.1212/wnl.0000000000004815 · Cited by 252
Pfeiffer, C. M., Fazili, Z., McCoy, L., Zhang, M., & Gunter, E. W. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.026955 · Cited by 245
“Inadequate folate status can increase the risk of offspring with neuraltube defects in women of childbearing age (2 ); be associated in the general population with certain cancers (3 ) and in the elderly with Alzheimer disease (4, 5); and produce increased homocysteine concentrations in plasma, an independent risk fac…”
BackgroundHomocysteine, B vitamin status, and cognitive function in the elderly
Duthie, S. J., Whalley, L. J., Collins, A. R., Leaper, S., Berger, K., & Deary, I. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.5.908 · Cited by 244
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer’s disease.
Lorenzl, S. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00004-4 · Cited by 243
Folic acid with or without vitamin B12 for cognition and dementia
Malouf, R., Grimley Evans, J., & Areosa Sastre, A. (2003) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004514 · Cited by 243
A Functional Transsulfuration Pathway in the Brain Links to Glutathione Homeostasis
Vitvitsky, V., Thomas, M., Ghorpade, A., Gendelman, H. E., & Banerjee, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602799200 · Cited by 241
Nutrition for the ageing brain: Towards evidence for an optimal diet
Vauzour, D., Camprubi-Robles, M., Miquel-Kergoat, S., Andres-Lacueva, C., Bánáti, D., Barberger-Gateau, P., Bowman, G. L., Caberlotto, L., Clarke, R., Hogervorst, E., et al. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.010 · Cited by 241
“Clinical evidence has demonstrated a correlation between elevated plasma (Hcy) and the occurrence of AD and thus, hyperhomocysteinemia has been suggested as an important risk factor of AD (Obeid and Herrmann, 2006; Seshadri et al., 2002).”
Homocysteine, white matter hyperintensities, and cognition in healthy elderly people
Dufouil, C., Alpérovitch, A., Ducros, V., & Tzourio, C. (2003) · Annals of Neurology · doi:10.1002/ana.10440 · Cited by 241
“More recently, in a sample of the Framingham Study, it has been shown that the risk of AD was nearly doubled in people with high levels of Hcy.11 At baseline, Hcy levels were measured in 1,092 of the study’s participants, none of whom had dementia.”
BackgroundResultInfluentialVascular Basis of Alzheimer's Pathogenesis
de la TORRE, J. C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04817.x · Cited by 238
Folic acid, ageing, depression, and dementia
Reynolds, E. H. (2002) · BMJ · doi:10.1136/bmj.324.7352.1512 · Cited by 239
Valuck, R. J., & Ruscin, J. M. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.08.015 · Cited by 239
“Furthermore, vitamin B12 deficiency-induced hyperhomocysteinemia and its relationship to other disorders, such as cardiovascular disease and Alzheimer’s disease, is increasingly being explored [9–12].”
BackgroundBODIPY‐Based Fluorescent Probes for Biothiols
Zhang, J., Wang, N., Ji, X., Tao, Y., Wang, J., & Zhao, W. (2020) · Chemistry – A European Journal · doi:10.1002/chem.201904470 · Cited by 237
Lee, L. C.-C., & Lo, K. K.-W. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00629 · Cited by 238
The role of diet in cognitive decline
Solfrizzi, V., Panza, F., & Capurso, A. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0766-8 · Cited by 237
“An increased plasma homocysteine level seems to be a strong, independent risk factor for the development of dementia and AD, suggesting that the elevated homocysteine levels precede the onset of dementia, not resulting from dementia-related nutritional and vitamin deficiencies (Seshadri et al., 2002).”
BackgroundFluorescence turn-on probe for homocysteine and cysteine in water
Lee, K.-S., Kim, T.-K., Lee, J. H., Kim, H.-J., & Hong, J.-I. (2008) · Chemical Communications · doi:10.1039/b814581d · Cited by 238
Relation of Higher Folate Intake to Lower Risk of Alzheimer Disease in the Elderly
Luchsinger, J. A., Tang, M.-X., Miller, J., Green, R., & Mayeux, R. (2007) · Archives of Neurology · doi:10.1001/archneur.64.1.86 · Cited by 237
“Elevated plasma homocysteine level, a risk factor for cardiovascular disease(2) and stroke,(3) may be related to higher AD risk.(4) Deficiencies of folate and vitamins B12 (cyanocobalamin) and B6 (pyridoxine hydrochloride) intake increase homocysteine levels.”
BackgroundCardiovascular risk factors and Alzheimer’s disease
Luchsinger, J. A., & Mayeux, R. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0056-z · Cited by 238
Autocrine and Paracrine Calcium Signaling by the CD38/NAD+/Cyclic ADP‐Ribose System
DE FLORA, A., ZOCCHI, E., GUIDA, L., FRANCO, L., & BRUZZONE, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1322.021 · Cited by 237
Qi, Y., Huang, Y., Li, B., Zeng, F., & Wu, S. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04407 · Cited by 235
Aging of the brain, entropy, and Alzheimer disease
Drachman, D. A. (2006) · Neurology · doi:10.1212/01.wnl.0000240127.89601.83 · Cited by 235
Hyperhomocysteinemia, Oxidative Stress, and Cerebral Vascular Dysfunction
Faraci, F. M., & Lentz, S. R. (2004) · Stroke · doi:10.1161/01.str.0000115161.10646.67 · Cited by 233
A cysteine-selective fluorescent probe for the cellular detection of cysteine
Jung, H. S., Han, J. H., Pradhan, T., Kim, S., Lee, S. W., Sessler, J. L., Kim, T. W., Kang, C., & Kim, J. S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.040 · Cited by 233
Dementia, stroke, and vascular risk factors; a review
Sahathevan, R., Brodtmann, A., & Donnan, G. A. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00731.x · Cited by 230
Kidney function is associated with the rate of cognitive decline in the elderly
Buchman, A. S., Tanne, D., Boyle, P. A., Shah, R. C., Leurgans, S. E., & Bennett, D. A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b72629 · Cited by 230
A New Fluorescent Chemodosimeter for Hg2+: Selectivity, Sensitivity, and Resistance to Cys and GSH
Du, J., Fan, J., Peng, X., Sun, P., Wang, J., Li, H., & Sun, S. (2010) · Organic Letters · doi:10.1021/ol902590g · Cited by 226
Biofortification of Pulse Crops: Status and Future Perspectives
Jha, A. B., & Warkentin, T. D. (2020) · Plants · doi:10.3390/plants9010073 · Cited by 226
“Deficiency of folates has been associated with greater risk of various chronic diseases, such as neural tube defects [72], impaired cognitive function [73], Alzheimer’s disease [74], cardiovascular diseases [75], and certain types of cancers [76].”
BackgroundSontag, E., Nunbhakdi-Craig, V., Sontag, J.-M., Diaz-Arrastia, R., Ogris, E., Dayal, S., Lentz, S. R., Arning, E., & Bottiglieri, T. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3316-06.2007 · Cited by 225
“Elevated plasma levels of homocysteine (Hcy) has emerged as a significant risk factor for many age-related diseases, including AD and dementia (Seshadri et al., 2002; Morris, 2003; Irizarry et al., 2005; Ravaglia et al., 2005).”
BackgroundDisturbed homocysteine metabolism is associated with cancer
Hasan, T., Arora, R., Bansal, A. K., Bhattacharya, R., Sharma, G. S., & Singh, L. R. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0216-4 · Cited by 223
Mixed Dementia—the Most Common Cause of Dementia
KORCZYN, A. D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04807.x · Cited by 219
Vascular Dementia: Distinguishing Characteristics, Treatment, and Prevention
Román, G. C. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.5155.x · Cited by 219
Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging
Bowman, G. L., Silbert, L. C., Howieson, D., Dodge, H. H., Traber, M. G., Frei, B., Kaye, J. A., Shannon, J., & Quinn, J. F. (2012) · Neurology · doi:10.1212/wnl.0b013e3182436598 · Cited by 218
Moos, M.-K., Dunlop, A. L., Jack, B. W., Nelson, L., Coonrod, D. V., Long, R., Boggess, K., & Gardiner, P. M. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.08.060 · Cited by 217
Daulatzai, M. A. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23634 · Cited by 217
“…unhealthy diet and nutrition, alcohol excess, some metals, pesticides, diabetes, hypertension, inflammation, brain trauma, and education level (Seshadri et al., 2002; Fleminger et al., 2003; Carrillo et al., 2009; Daulatzai, 2010, 2012a,b, 2013a, 2014, 2015a–c; Zhang and Le, 2010; Sivanandam…”
BackgroundCho, E., Zeisel, S. H., Jacques, P., Selhub, J., Dougherty, L., Colditz, G. A., & Willett, W. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.905 · Cited by 217
“An elevated plasma concentration of total homocysteine (tHcy) is a risk factor for cardiovascular disease (11–16), dementia (16, 17), Alzheimer disease (16, 17), some cancers (18–22), and mortality (23, 24).”
BackgroundSelf-citationThe Worldwide Challenge of the Dementias: A Role for B Vitamins and Homocysteine?
Smith, A. D. (2008) · Food and Nutrition Bulletin · doi:10.1177/15648265080292s119 · Cited by 216
“Seshadri [75] 2002 1,092 in community 8 Diagnosis of dementia or Alzheimer’s disease No association with serum folate, vitamin B6, and vitamin B12, although total homocysteine was related.”
BackgroundElevated levels of homocysteine compromise blood-brain barrier integrity in mice
Kamath, A. F., Chauhan, A. K., Kisucka, J., Dole, V. S., Loscalzo, J., Handy, D. E., & Wagner, D. D. (2006) · Blood · doi:10.1182/blood-2005-06-2506 · Cited by 212
“Moreover, a plasma Hcy level greater than 14 μM increases the risk of Alzheimer’s disease (AD) by almost two-fold.(3) The pathological effects of Hcy in these diseases and the possible role of Hcy in blood-brain barrier (BBB) degradation have yet to be explored.”
Jiang, C., Huang, H., Kang, X., Yang, L., Xi, Z., Sun, H., Pluth, M. D., & Yi, L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01096k · Cited by 209
The Many Facets of Hyperhomocysteinemia: Studies from the Framingham Cohorts
Selhub, J. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1726s · Cited by 212
Self-citationA turn-on fluorescent sensor for the discrimination of cystein from homocystein and glutathione
Niu, L.-Y., Guan, Y.-S., Chen, Y.-Z., Wu, L.-Z., Tung, C.-H., & Yang, Q.-Z. (2013) · Chemical Communications · doi:10.1039/c2cc38429a · Cited by 208
Paraoxonases-1, -2 and -3: What are their functions?
Furlong, C. E., Marsillach, J., Jarvik, G. P., & Costa, L. G. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.05.036 · Cited by 208
Review: Cognitive Function in Chronic Kidney Disease
Madero, M., Gul, A., & Sarnak, M. J. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00384.x · Cited by 206
Gender differences in dementia risk factors
Azad, N. A., Al Bugami, M., & Loy-English, I. (2007) · Gender Medicine · doi:10.1016/s1550-8579(07)80026-x · Cited by 204
Clarke, R., Bennett, D., Parish, S., Lewington, S., Skeaff, M., Eussen, S. J., Lewerin, C., Stott, D. J., Armitage, J., Hankey, G. J., et al. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.076349 · Cited by 204
“Subsequently, prospective studies in healthy older people reported that individuals with homocysteine concentrations $14 mmol/L had a 2-fold higher risk of Alzheimer disease after adjustment for known risk factors (5, 6).”
BackgroundImaging the progression of Alzheimer pathology through the brain
Smith, A. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082107399 · Cited by 206
Hailpern, S. M., Melamed, M. L., Cohen, H. W., & Hostetter, T. H. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006101165 · Cited by 206
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13932 · Cited by 205
“It is known that homocysteine is a significant risk factor for AD (Seshadri et al. 2002), probably through the generation of amyloid angiopathy.”
BackgroundCognitive decline, dietary factors and gut–brain interactions
Caracciolo, B., Xu, W., Collins, S., & Fratiglioni, L. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.11.011 · Cited by 204
Honjo, K., van Reekum, R., & Verhoeff, N. P. L. G. (2009) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2008.12.001 · Cited by 204
“pylori infection could result in low vitamin B12 and folate levels, causing secondary hyperhomocysteinemia, which could trigger endothelial damage and result in vascular atherothrombotic disorders and AD [92].”
BackgroundVegetarianism and vitamin B-12 (cobalamin) deficiency
Antony, A. C. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.1.3 · Cited by 204
Zhang, J., Wang, J., Liu, J., Ning, L., Zhu, X., Yu, B., Liu, X., Yao, X., & Zhang, H. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00377 · Cited by 204
Low vitamin B-12 status and risk of cognitive decline in older adults
Clarke, R., Birks, J., Nexo, E., Ueland, P. M., Schneede, J., Scott, J., Molloy, A., & Evans, J. G. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1384 · Cited by 203
“Some prospective cohort studies (16, 17), but not all (18), have also reported associations of dementia with elevated tHcy concentrations.”
BackgroundOxidative imbalance in patients with mild cognitive impairment and Alzheimer’s disease
GUIDI, I., GALIMBERTI, D., LONATI, S., NOVEMBRINO, C., BAMONTI, F., TIRITICCO, M., FENOGLIO, C., VENTURELLI, E., BARON, P., & BRESOLIN, N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.001 · Cited by 203
The methionine-homocysteine cycle and its effects on cognitive diseases.
Miller, A. L. (2003) · PubMed · Cited by 281
Exercise and cognition in older adults: is there a role for resistance training programmes?
Liu-Ambrose, T., & Donaldson, M. G. (2009) · British Journal of Sports Medicine · doi:10.1136/bjsm.2008.055616 · Cited by 202
Lu, W., Jiao, Y., Gao, Y., Qiao, J., Mozneb, M., Shuang, S., Dong, C., & Li, C.-Z. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b16710 · Cited by 201
Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies
Tinelli, C., Di Pino, A., Ficulle, E., Marcelli, S., & Feligioni, M. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00049 · Cited by 199
“As an example, a longitudinal study, lasting ≥8 years, including 1,092 individuals with dementia (mean age = 76), showed that the risk of developing AD was doubled in patients with levels of HCys > 14 μmol/l (72).”
BackgroundFolate, colorectal carcinogenesis, and DNA methylation: Lessons from animal studies
Kim, Y. (2004) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20025 · Cited by 200
The rate of conversion of mild cognitive impairment to dementia: predictive role of depression
Gabryelewicz, T., Styczynska, M., Luczywek, E., Barczak, A., Pfeffer, A., Androsiuk, W., Chodakowska‐Zebrowska, M., Wasiak, B., Peplonska, B., & Barcikowska, M. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1716 · Cited by 199
“A few studies showed that homocysteine levels correlate inversely Copyright # 2006 John Wiley & Sons, Ltd. with cognitive performance (Duthie et al., 2002), and an increase in plasma homocysteine is an independent risk factor for the development of AD (Seshadri et al., 2002).”
BackgroundBlood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging
Ravaglia, G., Forti, P., Maioli, F., Chiappelli, M., Montesi, F., Tumini, E., Mariani, E., Licastro, F., & Patterson, C. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.012 · Cited by 198
Direct Detection of Homocysteine
Wang, W., Escobedo, J. O., Lawrence, C. M., & Strongin, R. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0318838 · Cited by 198
van Himbergen, T. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.670 · Cited by 198
M. Bakulski, K., S. Rozek, L., C. Dolinoy, D., L. Paulson, H., & Hu, H. (2012) · Current Alzheimer Research · doi:10.2174/156720512800617991 · Cited by 197
Dietary niacin and the risk of incident Alzheimer’s disease and of cognitive decline
Morris, M. C. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.025858 · Cited by 196
Metadata
- Authors
- Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A.
- Affiliations
- Boston University (US)
- Tufts University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-02-14
- Volume
- 346
- Issue
- 7
- Pages
- 476-483
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2052588755
- Cited by
- 3,237
- References
- 55
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 82 · 2023: 79 · 2022: 90 · 2021: 102 · 2020: 91 · 2019: 133 · 2018: 132 · 2017: 138 · 2016: 138 · 2015: 149 · 2014: 174 · 2013: 154 · 2012: 155
- FWCI
- 111.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc038038-022)
- National Institute on Aging (5R01 AG 08122-11, 5R01-AG16495-02, R01AG016495, R01AG008122)
- National Heart, Lung, and Blood Institute (N01-HC-38038)
- National Institute of Neurological Disorders and Stroke (5R01 NS 17950-19, R01NS017950)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- plasma homocysteine, dementia, Alzheimer's disease, risk factors, newly diagnosed dementia, folic acid, vitamin B12, vitamin B6, apolipoprotein E, Framingham Heart Study, cognitive decline
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Dementia, Female, Homocysteine, Humans, Male, Risk Factors, Cohort Studies, Confounding Factors, Epidemiologic, Multivariate Analysis, Proportional Hazards Models, Hyperhomocysteinemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.